Cargando…

Human D-aspartate Oxidase: A Key Player in D-aspartate Metabolism

In recent years, the D-enantiomers of amino acids have been recognized as natural molecules present in all kingdoms, playing a variety of biological roles. In humans, d-serine and d-aspartate attracted attention for their presence in the central nervous system. Here, we focus on d-aspartate, which i...

Descripción completa

Detalles Bibliográficos
Autores principales: Pollegioni, Loredano, Molla, Gianluca, Sacchi, Silvia, Murtas, Giulia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260693/
https://www.ncbi.nlm.nih.gov/pubmed/34250021
http://dx.doi.org/10.3389/fmolb.2021.689719
_version_ 1783718860205064192
author Pollegioni, Loredano
Molla, Gianluca
Sacchi, Silvia
Murtas, Giulia
author_facet Pollegioni, Loredano
Molla, Gianluca
Sacchi, Silvia
Murtas, Giulia
author_sort Pollegioni, Loredano
collection PubMed
description In recent years, the D-enantiomers of amino acids have been recognized as natural molecules present in all kingdoms, playing a variety of biological roles. In humans, d-serine and d-aspartate attracted attention for their presence in the central nervous system. Here, we focus on d-aspartate, which is involved in glutamatergic neurotransmission and the synthesis of various hormones. The biosynthesis of d-aspartate is still obscure, while its degradation is due to the peroxisomal flavin adenine dinucleotide (FAD)-containing enzyme d-aspartate oxidase. d-Aspartate emergence is strictly controlled: levels decrease in brain within the first days of life while increasing in endocrine glands postnatally and through adulthood. The human d-aspartate oxidase (hDASPO) belongs to the d-amino acid oxidase-like family: its tertiary structure closely resembles that of human d-amino acid oxidase (hDAAO), the enzyme that degrades neutral and basic d-amino acids. The structure-function relationships of the physiological isoform of hDASPO (named hDASPO_341) and the regulation of gene expression and distribution and properties of the longer isoform hDASPO_369 have all been recently elucidated. Beyond the substrate preference, hDASPO and hDAAO also differ in kinetic efficiency, FAD-binding affinity, pH profile, and oligomeric state. Such differences suggest that evolution diverged to create two different ways to modulate d-aspartate and d-serine levels in the human brain. Current knowledge about hDASPO is shedding light on the molecular mechanisms underlying the modulation of d-aspartate levels in human tissues and is pushing novel, targeted therapeutic strategies. Now, it has been proposed that dysfunction in NMDA receptor-mediated neurotransmission is caused by disrupted d-aspartate metabolism in the nervous system during the onset of various disorders (such as schizophrenia): the design of suitable hDASPO inhibitors aimed at increasing d-aspartate levels thus represents a novel and useful form of therapy.
format Online
Article
Text
id pubmed-8260693
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-82606932021-07-08 Human D-aspartate Oxidase: A Key Player in D-aspartate Metabolism Pollegioni, Loredano Molla, Gianluca Sacchi, Silvia Murtas, Giulia Front Mol Biosci Molecular Biosciences In recent years, the D-enantiomers of amino acids have been recognized as natural molecules present in all kingdoms, playing a variety of biological roles. In humans, d-serine and d-aspartate attracted attention for their presence in the central nervous system. Here, we focus on d-aspartate, which is involved in glutamatergic neurotransmission and the synthesis of various hormones. The biosynthesis of d-aspartate is still obscure, while its degradation is due to the peroxisomal flavin adenine dinucleotide (FAD)-containing enzyme d-aspartate oxidase. d-Aspartate emergence is strictly controlled: levels decrease in brain within the first days of life while increasing in endocrine glands postnatally and through adulthood. The human d-aspartate oxidase (hDASPO) belongs to the d-amino acid oxidase-like family: its tertiary structure closely resembles that of human d-amino acid oxidase (hDAAO), the enzyme that degrades neutral and basic d-amino acids. The structure-function relationships of the physiological isoform of hDASPO (named hDASPO_341) and the regulation of gene expression and distribution and properties of the longer isoform hDASPO_369 have all been recently elucidated. Beyond the substrate preference, hDASPO and hDAAO also differ in kinetic efficiency, FAD-binding affinity, pH profile, and oligomeric state. Such differences suggest that evolution diverged to create two different ways to modulate d-aspartate and d-serine levels in the human brain. Current knowledge about hDASPO is shedding light on the molecular mechanisms underlying the modulation of d-aspartate levels in human tissues and is pushing novel, targeted therapeutic strategies. Now, it has been proposed that dysfunction in NMDA receptor-mediated neurotransmission is caused by disrupted d-aspartate metabolism in the nervous system during the onset of various disorders (such as schizophrenia): the design of suitable hDASPO inhibitors aimed at increasing d-aspartate levels thus represents a novel and useful form of therapy. Frontiers Media S.A. 2021-06-23 /pmc/articles/PMC8260693/ /pubmed/34250021 http://dx.doi.org/10.3389/fmolb.2021.689719 Text en Copyright © 2021 Pollegioni, Molla, Sacchi and Murtas. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Molecular Biosciences
Pollegioni, Loredano
Molla, Gianluca
Sacchi, Silvia
Murtas, Giulia
Human D-aspartate Oxidase: A Key Player in D-aspartate Metabolism
title Human D-aspartate Oxidase: A Key Player in D-aspartate Metabolism
title_full Human D-aspartate Oxidase: A Key Player in D-aspartate Metabolism
title_fullStr Human D-aspartate Oxidase: A Key Player in D-aspartate Metabolism
title_full_unstemmed Human D-aspartate Oxidase: A Key Player in D-aspartate Metabolism
title_short Human D-aspartate Oxidase: A Key Player in D-aspartate Metabolism
title_sort human d-aspartate oxidase: a key player in d-aspartate metabolism
topic Molecular Biosciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260693/
https://www.ncbi.nlm.nih.gov/pubmed/34250021
http://dx.doi.org/10.3389/fmolb.2021.689719
work_keys_str_mv AT pollegioniloredano humandaspartateoxidaseakeyplayerindaspartatemetabolism
AT mollagianluca humandaspartateoxidaseakeyplayerindaspartatemetabolism
AT sacchisilvia humandaspartateoxidaseakeyplayerindaspartatemetabolism
AT murtasgiulia humandaspartateoxidaseakeyplayerindaspartatemetabolism